Cardio-ankle vascular index in heterozygous familial hypercholesterolemia

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 5, 2012, Pages 453-461

  Soska, Vladimir ^a   Dobsak, Petr ^b   Dusek, Ladislav ^a   Shirai, Kohji ^c   Jarkovsky, Jiri ^a   Novakova, Marie ^a   Brhel, Petr ^b   Stastna, Jana ^a   Fajkusova, Lenka ^d   Freiberger, Tomas ^e   Yambe, Tomoyuki ^f  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^e Centre for Cardiovascular Surgery and Transplantation   (Czech Republic)

^f TOHOKU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cardio ankle vascular index; Ezetimibe; Familial hypercholesterolemia; Statins

Indexed keywords

ATORVASTATIN; BMI1 PROTEIN; FLUINDOSTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGE; ARTICLE; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; COMPUTER PROGRAM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; ANKLE BRACHIAL INDEX; FEMALE; HEART; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED;

EID: 84861631383     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.9639     Document Type: Article

References (47)

1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366: 1267-1278
2. Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 2003; 361: 2005-2016
3. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA, 2004; 291: 1071-1080
4. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 1997; 96: 1432-1437
5. Davis PH, Dawson JD, Mahoney LT, Lauer RM: Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation, 1999; 100: 838-842
6. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD, Evans G: Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol, 2000; 151: 478-487
7. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC: Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke, 2001; 32: 454-460
8. Zureik M, Bureau JM, Temmar M, Adamopoulos C, Courbon D, Bean K, Touboul PJ, Benetos A, Ducimetière P: Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension, 2003; 41: 519-527
9. Munakata M, Sakuraba J, Tayama J, Furuta T, Yusa A, Nunokawa T, Yoshinaga K, Toyota T: Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res, 2005; 28: 9-14
10. Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, Shido N, Tanaka N, Chikamori T, Yamashina A: Brachial ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J, 2005; 69: 815-822
11. Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M: Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res, 2003; 26: 163-167
12. Imanishi R, Seto S, Toda G, Yoshida M, Ohtsuru A, Koide Y, Baba T, Yano K: High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res, 2004; 27: 71-78
13. Woodside JV, McMahon R, Gallagher AM, Cran GW, Boreham CA, Murray LJ, Strain JJ, McNulty H, Robson PJ, Brown KS, Whitehead AS, Savage M, Young IS: Total homocysteine is not a determinant of arterial pulse wave velocity in young healthy adults. Atherosclerosis, 2004; 177: 337-344
14. Yambe T, Yoshizawa M, Saijo Y, Yamaguchi T, Shibata M, Konno S, Nitta S, Kuwayama T: Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother, 2004; 58: S95-S98
15. Kubozono T, Miyata M, Ueyama K, Nagaki A, Otsuji Y, Kusano K, Kubozono O, Tei C: Clinical Significance and Reproducibility of New Arterial Distensibility Index. Circ J, 2007; 71: 89-94
16. Huck CJ, Bronas UG, Williamson EB, Draheim CC, Duprez DA, Dengel DR: Noninvasive measurements of arterial stiffness: repeatability and interrelationships with endothelial function and arterial morphology measures. Vasc Health Risk Manag, 2007; 3: 343-349
17. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb, 2006; 13: 101-107
18. Izuhara M, Shioji K, Kadota S, Baba O, Takeuchi Y, Uegaito T, Mutsuo S, Matsuda M: Relationship of cardioankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J, 2008; 72: 1762-1767
19. Miyoshi T, Doi M, Hirohata S, Sakane K, Kamikawa S, Kitawaki T, Kaji Y, Kusano KF, Ninomiya Y, Kusachi S: Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb, 2010; 17: 249-258
20. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, Enomoto D, Miyoshi K, Fukuoka T, Higaki J: Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res, 2007; 30: 335-340
21. Yambe T, Meng X, Hou X, Wang Q, Sekine K, Shiraishi Y, Watanabe M, Yamaguchi T, Shibata M, Kuwayama T, Maruyama M, Konno S, Nitta S: Cardio-ankle vascular index (CAVI) for the monitoring of the atherosclerosis after heart transplantation. Biomed Pharmacother, 2005; 59: S177-S179
22. Wakabayashi I, Masuda H: Effects of age on the relationship between cardio-ankle vascular index and atherosclerotic progression in patients with type 2 diabetes mellitus. Nippon Ronen Igakkai Zasshi, 2006; 43: 217-221
23. Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Ooishi M, Kotani K, Ogawa Y: Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res, 2008; 31: 1921-1930
24. Miyashita Y, Endo K, Saiki A, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb, 2009; 16: 539-545
25. Miyashita Y, Endo K, Saiki A, Ban N, Nagumo A, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effect of ezetimibe monotherapy on lipid metabolism and arterial stiffness assessed by cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb, 2010; 17: 1070-1076
26. Noike H, Nakamura K, Sugiyama Y, Iizuka T, Shimizu K, Takahashi M, Hirano K, Suzuki M, Mikamo H, Nakagami T, Shirai K: Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb, 2010; 17: 517-525
27. Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, Hopkins PN: Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol, 1993; 72: 171-176
28. US MedPed Program, www.medped.org, 2005
29. Duskova L, Kopecková L, Jansova E, Tichy L, Freiberger T, Zaplet-aletalova P, Soska V, Ravcuková B, Fajkusova L: An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia. Atherosclerosis, 2011; 216: 139-145
30. Goldmann R, Tichy L, Freiberger T, Zaplet-aletalova P, Letocha O, Soska V, Fajkus J, Fajkusova L: Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia. BMC Med Genet, 2010; 11: 115
31. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
32. Bramwell JC, Hill AV: Velocity of the pulse wave in man. Proc Roy Soc B, 1922; 93: 298-306
33. Goldstein JL, Hobbs HH, Brown MS: Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Disease 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, Valle D, pp 2863-2913, McGraw-Hill Publisher, New York, USA, 2001
34. Myant NB: Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Atherosclerosis, 1993; 104: 1-18
35. Thompson GR: Familial hypercholesterolaemia. In: Lipoproteins in Health and Disease, ed by Betteridge DJ, Illingworth DR, Shepherd J, pp673-692, Arnold Publisher, London, UK, 1999
36. Choumerianou DM, Dedoussis GV: Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background. Clin Chem Lab Med, 2005; 43: 793-801
37. Slack J: Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet, 1969; 2: 1380-1382
38. Stone NJ, Levy RI, Fredrickson DS, Verter J: Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation, 1974; 49: 476-488
39. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H: Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J, 2008; 72: 598-604
40. Endo A, Tsujita Y, Kuroda M, Tanzawa K: Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem, 1971; 77: 31-36
41. Wassmann S, Nickenig G: Improvement of Endothelial Function by HMG-CoA Reductase Inhibitors. Drug News Perspect, 2002;15: 85-92
42. Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE: Reductions in allcause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J, 2008; 29: 2625-2633
43. Mohrschladt MF, Westendorp RG, Gevers Leuven JA, Smelt AH: Cardiovascular disease and mortality in statintreated patients with familial hypercholesterolemia. Atherosclerosis, 2004;172: 329-335
44. Harada-Shiba M, Sugisawa T, Makino H, Abe M, Tsushima M, Yoshimasa Y, Yamashita T, Miyamoto Y, Yamamoto A, Tomoike H, Yokoyama S: Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia. J Atheroscler Thromb, 2010; 17: 667-674
45. Hongo M, Tsutsui H, Mawatari E, Hidaka H, Kumazaki S, Yazaki Y, Takahashi M, Kinoshita O, Ikeda U: Fluvastatin improves arterial stiffness in patients with coronary artery disease and hyperlipidemia: a 5-year follow-up study. Circ J, 2008; 72: 722-728
46. Cifkova R, Skodova Z, Bruthans J, Adamkova V, Jozifova M, Galovcova M, Wohlfahrt P, Krajcoviechova A, Poledne R, Stavek P, Lanska V: Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis, 2010; 211: 676-681
47. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, Matsuda S, Miyazaki Y, Matsuda T, Hiratsuka A, Matsuzaki M: Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J, 2007; 71: 1710-1714